Tezcan E - Search Results

1

Quetiapine augmentation in patients with treatment resistant obsessive-compulsive disorder: a single-blind, placebo-controlled study.

Atmaca M, Kuloglu M, Tezcan E, Gecici O. Atmaca M, et al. Among authors: tezcan e. Int Clin Psychopharmacol. 2002 May;17(3):115-9. doi: 10.1097/00004850-200205000-00004. Int Clin Psychopharmacol. 2002. PMID: 11981352 Clinical Trial.

2

Antioxidant enzyme activities and malondialdehyde levels in patients with obsessive-compulsive disorder.

Kuloglu M, Atmaca M, Tezcan E, Gecici O, Tunckol H, Ustundag B. Kuloglu M, et al. Among authors: tezcan e. Neuropsychobiology. 2002;46(1):27-32. doi: 10.1159/000063573. Neuropsychobiology. 2002. PMID: 12207144

3

Quetiapine-associated and dose-related hypomania in a woman with schizophrenia.

Atmaca M, Kuloglu M, Buyukbayram A, Tezcan E. Atmaca M, et al. Among authors: tezcan e. Eur Psychiatry. 2002 Sep;17(5):292-3. doi: 10.1016/s0924-9338(02)00675-2. Eur Psychiatry. 2002. PMID: 12381500 No abstract available.

4

Efficacy of citalopram and moclobemide in patients with social phobia: some preliminary findings.

Atmaca M, Kuloglu M, Tezcan E, Unal A. Atmaca M, et al. Among authors: tezcan e. Hum Psychopharmacol. 2002 Dec;17(8):401-5. doi: 10.1002/hup.436. Hum Psychopharmacol. 2002. PMID: 12457375 Clinical Trial.

5

Quetiapine is not associated with increase in prolactin secretion in contrast to haloperidol.

Atmaca M, Kuloglu M, Tezcan E, Canatan H, Gecici O. Atmaca M, et al. Among authors: tezcan e. Arch Med Res. 2002 Nov-Dec;33(6):562-5. doi: 10.1016/s0188-4409(02)00403-4. Arch Med Res. 2002. PMID: 12505103 Clinical Trial.

6

Fluoxetine versus Vitex agnus castus extract in the treatment of premenstrual dysphoric disorder.

Atmaca M, Kumru S, Tezcan E. Atmaca M, et al. Among authors: tezcan e. Hum Psychopharmacol. 2003 Apr;18(3):191-5. doi: 10.1002/hup.470. Hum Psychopharmacol. 2003. PMID: 12672170 Clinical Trial.

7

Serum leptin and triglyceride levels in patients on treatment with atypical antipsychotics.

Atmaca M, Kuloglu M, Tezcan E, Ustundag B. Atmaca M, et al. Among authors: tezcan e. J Clin Psychiatry. 2003 May;64(5):598-604. doi: 10.4088/jcp.v64n0516. J Clin Psychiatry. 2003. PMID: 12755665

8

Switching to tianeptine in patients with antidepressant-induced sexual dysfunction.

Atmaca M, Kuloglu M, Tezcan E, Buyukbayram A. Atmaca M, et al. Among authors: tezcan e. Hum Psychopharmacol. 2003 Jun;18(4):277-80. doi: 10.1002/hup.479. Hum Psychopharmacol. 2003. PMID: 12766932 Clinical Trial.

9

Nizatidine treatment and its relationship with leptin levels in patients with olanzapine-induced weight gain.

Atmaca M, Kuloglu M, Tezcan E, Ustundag B. Atmaca M, et al. Among authors: tezcan e. Hum Psychopharmacol. 2003 Aug;18(6):457-61. doi: 10.1002/hup.514. Hum Psychopharmacol. 2003. PMID: 12923824 Clinical Trial.

10

Nizatidine for the treatment of patients with quetiapine-induced weight gain.

Atmaca M, Kuloglu M, Tezcan E, Ustundag B, Kilic N. Atmaca M, et al. Among authors: tezcan e. Hum Psychopharmacol. 2004 Jan;19(1):37-40. doi: 10.1002/hup.477. Hum Psychopharmacol. 2004. PMID: 14716710 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

95 results

Search Page

Filters